Three Fool.com contributors have identified no-brainer stocks to buy for under $100 right now. Here's why they picked two big ...

There's nothing like a top-level management departure to get investors worried about a publicly traded company. Investors in ...

Frost & Sullivan celebrates companies for their outstanding achievements at the Frost & Sullivan Best Practices Awards Gala ...

The results, released on Thursday, show that 93.49 per cent of women who appeared for the test qualified, compared to 91.61 ...

Incyte has hired veteran biotech executive Bill Meury to succeed Herve Hoppenot at the helm of the biopharmaceutical company.

Analysts reveal Dolan Duck, PYTHIA, and Snek as the best meme coins to invest in now, driven by community hype and good ...

Nektar Therapeutics said its embattled immune drug rezpeg significantly improved skin clearance rates in patients with atopic ...

Good morning! Today, we get deeper into the ousting of Nicole Verdun at the FDA, see promise from Vertex’s cell therapy for ...

Discover what makes Paris's biotech ecosystem so successful, as it just so happens to be one of the largest biotech clusters ...

Chemistry falls under the umbrella of natural sciences, alongside other fields like biology, geology and physics. Chemistry ...

Travere Therapeutics Inc. (NASDAQ:TVTX) is a biopharmaceutical company that identifies, develops, and delivers therapies to ...